PGR and triple-negative breast carcinoma: These categories include hormone receptor-positive (HR+), which express the estrogen or progesterone receptors (ER/PR) and are collectively referred to here as estrogen receptor-positive (ER+), human epidermal growth factor receptor positive (HER2+), or triple-negative breast cancer (TNBC), which lacks all of these receptors.